Schedule 13G ownership disclosure

Immune Therapeutics Inc

Security class unavailable · CUSIP: 45252A107

Event date: 2015-02-14

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
10,497,262
Percent of class
7.0000%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001354488-15-002822
Form type
SC 13G/A
Filer
DAILEY ROBERT JACKMAN
CIK
CIK 1570523
Filed
Jun 02, 2015
Reporting period
Feb 14, 2015
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub